These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2435984)

  • 41. The subcellular localization of phytanic acid oxidase in rat liver.
    Skjeldal OH; Stokke O
    Biochim Biophys Acta; 1987 Sep; 921(1):38-42. PubMed ID: 3620488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraorganellar localization of CoASH-independent phytanic acid oxidation in human liver peroxisomes.
    Pahan K; Singh I
    FEBS Lett; 1993 Oct; 333(1-2):154-8. PubMed ID: 8224157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
    Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
    Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new type of chondrodysplasia punctata associated with peroxisomal dysfunction.
    Poll-The BT; Maroteaux P; Narcy C; Quetin P; Guesnu M; Wanders RJ; Schutgens RB; Saudubray JM
    J Inherit Metab Dis; 1991; 14(3):361-3. PubMed ID: 1770792
    [No Abstract]   [Full Text] [Related]  

  • 45. Phytanic acid must be activated to phytanoyl-CoA prior to its alpha-oxidation in rat liver peroxisomes.
    Watkins PA; Howard AE; Mihalik SJ
    Biochim Biophys Acta; 1994 Oct; 1214(3):288-94. PubMed ID: 7918611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Occurrence of novel branched-chain fatty acids in Refsum's disease.
    Dulaney JT; Williams M; Evans JE; Costello CE; Kolodny EH
    Biochim Biophys Acta; 1978 Apr; 529(1):1-12. PubMed ID: 76480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
    Wanders RJ; Komen JC
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complementation analysis of peroxisomal disorders and classical Refsum.
    Poll-The BT; Skjeldal OH; Stokke O; Demaugre F; Saudubray JM
    Prog Clin Biol Res; 1990; 321():537-43. PubMed ID: 1691507
    [No Abstract]   [Full Text] [Related]  

  • 49. Diagnosis of Refsum's disease using [1-14C]phytanic acid as substrate.
    Poulos A
    Clin Genet; 1981 Oct; 20(4):247-53. PubMed ID: 6174257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Peroxisomes and peroxisomal diseases].
    Petelenz M; Gonciarz Z; Grzybek H; Panz B
    Postepy Hig Med Dosw; 1991; 45(1-2):77-99. PubMed ID: 1717967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peroxisome mosaicism in the livers of peroxisomal deficiency patients.
    Espeel M; Mandel H; Poggi F; Smeitink JA; Wanders RJ; Kerckaert I; Schutgens RB; Saudubray JM; Poll-The BT; Roels F
    Hepatology; 1995 Aug; 22(2):497-504. PubMed ID: 7635418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phenotypic heterogeneity in cultured skin fibroblasts from patients with disorders of peroxisome biogenesis belonging to the same complementation group.
    Wiemer EA; Out M; Schelen A; Wanders RJ; Schutgens RB; Van den Bosch H; Tager JM
    Biochim Biophys Acta; 1991 Oct; 1097(3):232-7. PubMed ID: 1718439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
    Poulos A; Singh H; Paton B; Sharp P; Derwas N
    Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.
    Poulos A; Sharp P; Fellenberg AJ; Johnson DW
    Eur J Pediatr; 1988 Feb; 147(2):143-7. PubMed ID: 2452737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of both peroxisomes and mitochondria in the alpha-oxidation of phytanic acid.
    Mihalik SJ; Soliman TM; Day RF; Watkins PA
    Prog Clin Biol Res; 1992; 375():239-44. PubMed ID: 1438369
    [No Abstract]   [Full Text] [Related]  

  • 56. Peroxisomal abnormality in fibroblasts from involved skin of CHILD syndrome. Case study and review of peroxisomal disorders in relation to skin disease.
    Emami S; Rizzo WB; Hanley KP; Taylor JM; Goldyne ME; Williams ML
    Arch Dermatol; 1992 Sep; 128(9):1213-22. PubMed ID: 1519936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase.
    Poulos A; Sharp P; Fellenberg AJ; Danks DM
    Hum Genet; 1985; 70(2):172-7. PubMed ID: 2408988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heredopathia atactica polyneurotiformis: therapeutic and pathogenetic aspects.
    Refsum S
    Riv Patol Nerv Ment; 1976 Jun; 97(3):115-26. PubMed ID: 74082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long chain fatty acids, and pipecolic acidemia: studies in four children.
    Budden SS; Kennaway NG; Buist NR; Poulos A; Weleber RG
    J Pediatr; 1986 Jan; 108(1):33-9. PubMed ID: 2418187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formic acid is a product of the alpha-oxidation of fatty acids by human skin fibroblasts: deficiency of formic acid production in peroxisome-deficient fibroblasts.
    Poulos A; Sharp P; Singh H; Johnson DW; Carey WF; Easton C
    Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):457-61. PubMed ID: 8503880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.